Skip to main content

Day: June 17, 2025

Cabka awarded EcoVadis Platinum Medal, Improving Sustainability Score

PRESS RELEASE Amsterdam, June 17, 2025 – Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard-to-recycle plastic waste into innovative Reusable Transport Packaging (RTP), and listed at Euronext Amsterdam proudly announces it has been awarded the Platinum Medal by EcoVadis. This distinction represents the highest level of recognition for sustainability management and marks a significant upgrade from last year’s Gold Medal. Cabka increased its EcoVadis score from 72 to 82 points, placing the company in the top 1% of all rated companies worldwide—a remarkable achievement and a testament to Cabka’s leadership in environmental, social, and governance (ESG) practices. A Leader in Responsible Business EcoVadis evaluates companies across key ESG areas, including environmental...

Continue reading

Everfield Enters Denmark with Acquisition of Hospitality Software Leader OnlinePOS

RANDERS, Denmark, June 17, 2025 (GLOBE NEWSWIRE) — Everfield, a European long-term software investor, announced the acquisition of OnlinePOS, Denmark’s trusted provider of point-of-sale (POS) solutions for the hospitality and events sector. This marks Everfield’s 30th acquisition across Europe, its first in Denmark, and a key step in expanding its Nordic footprint. Founded in 2008, OnlinePOS offers a modular POS platform for HORECA businesses. The solution combines traditional POS functionalities with advanced features such as QR self-service ordering, payment management, table and back-office administration, and offers over 30 third-party integrations.“At OnlinePOS, we’ve always aimed to simplify and modernize POS and payment solutions for HORECA businesses. We chose Everfield because of their long-term commitment to building...

Continue reading

FirstFarms’ top management is in position

The board has recruited internally for the CEO position. After a thorough assessment, the Board of Directors of FirstFarms A/S has appointed Søren Bredvig and Michael Hyldgaard as permanent Co-CEO’s of FirstFarms with immediate effect. Søren Bredvig and Michael Hyldgaard have served as interim Co-CEO’s since 1 May 2025. Both have, for a number of years in their respective roles as COO and CFO, demonstrated strong commitment, solid business understanding, and excellent leadership and collaboration skills. They will continue in their roles as COO and CFO while also taking on the overall responsibility for leading and operating the company. Chairman of the Board Asbjørn Børsting says:“We are pleased that it has been possible to recruit internally for such an important position. Søren and Michael are, with their deep knowledge...

Continue reading

2025 Venture Awards Celebrate Startups Partnering with Stellantis to Enhance Customer Experience

2025 Venture Awards Celebrate Startups Partnering with Stellantis to Enhance Customer ExperienceEight startups honored for advancing intuitive, personalized, and sustainable mobility solutions Winners selected across three categories – CARE, TECH and VALUE – for their real-world impact and scalability Startups play a central role in delivering breakthrough technologies that enhance the customer journey Interactive booth at MOVE 2025 in London (June 18-19, Main Entrance – Booth 1) will showcase award-winning startup innovations, AI, and accessible mobility solutionsAMSTERDAM, June 17, 2025 – Stellantis N.V. has honored six startup partners and two startups backed by the Stellantis Ventures capital fund with its fourth annual Venture Awards, recognizing bold innovations and high-impact collaborations that are shaping the future of mobility...

Continue reading

HighCo: EXCLUSIVE NEGOTIATIONS WITH SMP TO ACQUIRE ITS PROMOTION (SOGEC) AND MARKETING (BUDGETBOX) ACTIVITIES

Aix-en-Provence, 17 June 2025 (8.00 a.m.) HIGHCO: EXCLUSIVE NEGOTIATIONS WITH SMP SAS TO ACQUIRE ITS PROMOTION (SOGEC) AND MARKETING (BUDGETBOX) ACTIVITIES HighCo announces that it has entered exclusive negotiations with SMP SAS, a subsidiary of Groupe La Poste, over the acquisition of certain businesses offering promotional marketing solutions. As part of this deal, SMP SAS would sell the promotion execution and management businesses sold under the Sogec brand, as well as its retail media subsidiary BudgetBox. Sogec is a French agency specialising in omnichannel promotion activation. It offers a range of marketing solutions: discount coupon issuing and processing, digital cashback platform, Quoty app, games, loyalty programmes, etc. BudgetBox focuses on retail media. It creates targeted, personalised activation campaigns for brands and...

Continue reading

ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025

EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces its Q1 2025 business update and year-to-date highlights:Commercial traction: Following FDA market authorization, the Company met its Q1 objective for the limited initial phase of its US launch of the ARC-EX® System, hiring, training and deploying a field organization, establishing a sales and service process, building a roster of reference clinics, and selling ten systems. Technology advancement: The Company’s investigational ARC-IM® and ARC-BCI® platforms reached new milestones with the 4th and 5th successful BCI implants...

Continue reading

ANNUAL RESULTS 2024-25 FOR THE LEXIBOOK GROUP: ANNUAL REVENUE AT €74.0M (+26.3%). EBIT AND NET INCOME UP, AT €8.1M AND €7.4M RESPECTIVELY, THANKS TO AN EXCEPTIONAL COMBINATION OF POSITIVE FACTORS. UNCERTAIN OUTLOOK FOR THE 2025-26 FISCAL YE

                                             Les Ulis, June 17, 2025 at 7:00 a.m.ANNUAL RESULTS 2024-25 FOR THE LEXIBOOK GROUP: ANNUAL REVENUE AT €74.0M (+26.3%). EBIT AND NET INCOME UP, AT €8.1M AND €7.4M RESPECTIVELY, THANKS TO AN EXCEPTIONAL COMBINATION OF POSITIVE FACTORS. UNCERTAIN OUTLOOK FOR THE 2025-26 FISCAL YEAR DUE TO HIGH UNPREDICTABILITY REGARDING U.S. CUSTOMS DUTIES, FREIGHT COSTS, EXCHANGE RATES, AND CONSUMPTION.Annual Revenue: A record fiscal year after 5 consecutive years of growth. For the full fiscal year, which had already grown by 14.4% in 23-24, revenue rose again by 26.3% to €74.0M vs €58.6M a year earlier, notably thanks to the performance of licensed products.In a context of euro depreciation against the USD of around 1.0% over one year, and a very significant increase in freight costs, the Group’s margins...

Continue reading

Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational Progress

Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational ProgressContinued progress in advancing varoglutamstat in kidney disease based on encouraging data and expansion of IP portfolio Varoglutamstat’s pre-clinical dataset showing synergistic effect in combination with an SGLT-2 inhibitor in different treatment regimens Novel composition of matter patent for varoglutamstat granted after accelerated review in the U.S.; patent term to provide exclusivity through 2044 with subsequent opportunity for patent term extension Varoglutamstat meta-analysis data presented in oral presentation at ERA 2025 Preparations ongoing for Phase 2b of varoglutamstat in diabetic kidney disease (DKD) Management to host a conference call today at 3:00 pm CEST (9:00 am EDT)Halle (Saale) / Munich, Germany, June 17, 2025 – Vivoryon Therapeutics N.V....

Continue reading

ChampionsGate Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on June 20, 2025

Monterey, CA, June 16, 2025 (GLOBE NEWSWIRE) — ChampionsGate Acquisition Corporation (the “Company”) (Nasdaq: CHPGU), a blank check company, today announced that, commencing on June 20, 2025, holders of the 7,475,000 units (the “Units”) sold in the Company’s initial public offering (the “Offering”) including Units sold upon a full exercise of the underwriters’ over-allotment option, may elect to separately trade the Class A ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market (“NASDAQ”) under the symbol “CHPGU.” Any underlying Class A ordinary shares and rights that are separated will trade on the NASDAQ under the symbols “CHPG” and “CHPGR,” respectively. Holders of Units will need to have their brokers contact the Company’s transfer agent, Continental Stock...

Continue reading

Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering

New Taipei City, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced the pricing of its initial public offering (the “Offering”) of 2,666,667 ordinary shares (the “Ordinary Shares”) at a public offering price of $7.50 per share. The Company expects to receive aggregate gross proceeds of approximately $20 million, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on June 17,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.